Tri Locum Partners »

Tandem Diabetes Care shares owned by Tri Locum Partners

Quarter-by-quarter ownership of Tandem Diabetes Care (TNDM) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in Tandem Diabetes Care

Tip: Access up to 7 years of quarterly data

All positions including Tandem Diabetes Care held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tandem Diabetes Care by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 327k 35.41
2023-03-31 $17M 417k 40.61

More positions owned by Tri Locum Partners

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Silk Road Medical Inc Common (SILK)
Natera (NTRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Legend Biotech Corp Sponsored Ads (LEGN)
Merck & Co (MRK)
Vertex Pharmaceuticals Incorporated (VRTX)
Madrigal Pharmaceuticals (MDGL)
Baxter International (BAX)
Merus N V (MRUS)
Tandem Diabetes Care Com New (TNDM)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Regeneron Pharmaceuticals (REGN)

View all positions for Tri Locum Partners

Top funds holding Tandem Diabetes Care

BlackRock
Vanguard Group
Marshall Wace
Arrowpoint Asset Management
UBS Group
Jennison Associates
Henderson Group
Bellevue Group
Champlain Investment Partners
Fred Alger Management
Morgan Stanley
Park West Asset Management
Jennifer Ranahan
Jacobs Levy Equity Management
Two Sigma Advisers

View all funds holding Tandem Diabetes Care